Australia's most trusted
source of pharma news
Saturday, 14 December 2024
Posted 14 May 2024 AM
The public spotlight has been thrown on Australia's ailing PBS scheme with a scathing newspaper article published last weekend highlighting the injustice of medical access - using MSD's top-selling cancer drug, Keytruda, as a prime example.
The News Corp story pulled no punches, describing "a major failure of our health system which lags the world in funding lifesaving treatments" by comparing access between two patients with cancer caused by the same gene fault.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.